Effects of chronic nitric oxide synthase inhibition on V'O^sub 2max^ and exercise capacity in mice

• Published in: Naunyn-Schmiedeberg's archives of pharmacology 2017-03, Vol.390 (3), p.235
• Main Authors: Wojewoda, M, Przyborowski, K, Sitek, B, Zakrzewska, A, Mateuszuk, L, Zoladz, J A, Chlopicki, S
• Format: Article
• Language: English
• ISSN: 0028-1298; 1432-1912
• DOI: 10.1007/s00210-016-1318-3

Acute inhibition of NOS by L-NAME (N[omega]-nitro-L-arginine methyl ester) is known to decrease maximal oxygen consumption (V'O2max) and impair maximal exercise capacity, whereas the effects of chronic L-NAME treatment on V'O2max and exercise performance have not been studied so far. In this study, we analysed the effect of L-NAME treatment, (LN2 and LN12, respectively) on V'O2max and exercise capacity (in maximal incremental running and prolonged sub-maximal incremental running tests), systemic NO bioavailability (plasma nitrite (NO2 -) and nitrate (NO3 -)) and prostacyclin (PGI2) production in C57BL6/J mice. Mice treated with L-NAME for 2 weeks (LN2) displayed higher V'O2max and better running capacity than age-matched control mice. In LN2 mice, NO bioavailability was preserved, as evidenced by maintained NO2 - plasma concentration. PGI2 production was activated (increased 6-keto-PGF1[alpha] plasma concentration) and the number of circulating erythrocytes (RBC) and haemoglobin concentration were increased. In mice treated with L-NAME for 12 weeks (LN12), NO bioavailability was decreased (lower NO2 - plasma concentration), and 6-keto-PGF1[alpha] plasma concentration and RBC number were not elevated compared to age-matched control mice. However, LN12 mice still performed better during the maximal incremental running test despite having lower V'O2max. Interestingly, the LN12 mice showed poorer running capacity during the prolonged sub-maximal incremental running test. To conclude, short-term (2 weeks) but not long-term (12 weeks) treatment with L-NAME activated robust compensatory mechanisms involving preservation of NO2- plasma concentration, overproduction of PGI2 and increased number of RBCs, which might explain the fully preserved exercise capacity despite the inhibition of NOS.